Literature DB >> 9654536

Reversal of lesions of diabetic nephropathy after pancreas transplantation.

P Fioretto1, M W Steffes, D E Sutherland, F C Goetz, M Mauer.   

Abstract

BACKGROUND: In patients with type I diabetes mellitus who do not have uremia and have not received a kidney transplant, pancreas transplantation does not ameliorate established lesions of diabetic nephropathy within five years after transplantation, but the effects of longer periods of normoglycemia are unknown.
METHODS: We studied kidney function and performed renal biopsies before pancreas transplantation and 5 and 10 years thereafter in eight patients with type I diabetes but without uremia who had mild to advanced lesions of diabetic nephropathy at the time of transplantation. The biopsy samples were analyzed morphometrically.
RESULTS: All patients had persistently normal glycosylated hemoglobin values after transplantation. The median urinary albumin excretion rate was 103 mg per day before transplantation, 30 mg per day 5 years after transplantation, and 20 mg per day 10 years after transplantation (P=0.07 for the comparison of values at base line and at 5 years; P=0.11 for the comparison between base line and 10 years). The mean (+/-SD) creatinine clearance rate declined from 108+/-20 ml per minute per 1.73 m2 of body-surface area at base line to 74+/-16 ml per minute per 1.73 m2 at 5 years (P<0.001) and 74+/-14 ml per minute per 1.73 m2 at 10 years (P<0.001). The thickness of the glomerular and tubular basement membranes was similar at 5 years (570+/-64 and 928+/-173 nm, respectively) and at base line (594+/-81 and 911+/-133 nm, respectively) but had decreased by 10 years (to 404+/-38 and 690+/-111 nm, respectively; P<0.001 and P=0.004 for the comparisons with the base-line values). The mesangial fractional volume (the proportion of the glomerulus occupied by the mesangium) increased from base line (0.33+/-0.07) to 5 years (0.39+/-0.10, P=0.02) but had decreased at 10 years (0.27+/-0.02, P=0.05 for the comparison with the baseline value and P=0.006 for the comparison with the value at 5 years), mostly because of a reduction in mesangial matrix.
CONCLUSIONS: Pancreas transplantation can reverse the lesions of diabetic nephropathy, but reversal requires more than five years of normoglycemia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9654536     DOI: 10.1056/NEJM199807093390202

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  225 in total

Review 1.  Role of ACE inhibitors in patients with diabetes mellitus.

Authors:  D J Cordonnier; P Zaoui; S Halimi
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Surgical treatment of diabetes mellitus by islet cell and pancreas transplantation.

Authors:  S A White; R Kimber; P S Veitch; M L Nicholson
Journal:  Postgrad Med J       Date:  2001-06       Impact factor: 2.401

3.  Can islet cell transplantation treat diabetes?

Authors:  S A White; M L Nicholson; B J Hering
Journal:  BMJ       Date:  2000-09-16

4.  Pirfenidone for diabetic nephropathy.

Authors:  Kumar Sharma; Joachim H Ix; Anna V Mathew; Monique Cho; Axel Pflueger; Stephen R Dunn; Barbara Francos; Shoba Sharma; Bonita Falkner; Tracy A McGowan; Michael Donohue; Satish Ramachandrarao; Ronghui Xu; Fernando C Fervenza; Jeffrey B Kopp
Journal:  J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 10.121

5.  Kidney function can improve in patients with hypertensive CKD.

Authors:  Bo Hu; Crystal Gadegbeku; Michael S Lipkowitz; Stephen Rostand; Julia Lewis; Jackson T Wright; Lawrence J Appel; Tom Greene; Jennifer Gassman; Brad C Astor
Journal:  J Am Soc Nephrol       Date:  2012-03-08       Impact factor: 10.121

Review 6.  The meaning of microalbuminuria in type 1 diabetes: the need for a new paradigm.

Authors:  S G Adler; C C Nast
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

Review 7.  Pancreas and kidney transplantation.

Authors:  Jennifer Larsen; James Lane; Lynn Mack-Shipman
Journal:  Curr Diab Rep       Date:  2002-08       Impact factor: 4.810

Review 8.  Immune system modulation of kidney regeneration--mechanisms and implications.

Authors:  Hans-Joachim Anders
Journal:  Nat Rev Nephrol       Date:  2014-04-29       Impact factor: 28.314

Review 9.  The relationship between glucose control and the development and progression of diabetic nephropathy.

Authors:  Carrie A Phillips; Mark E Molitch
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

Review 10.  C-peptide: a new potential in the treatment of diabetic nephropathy.

Authors:  J Wahren; K Ekberg; B Samnegård; B L Johansson
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.